CD106 Identifies a Subpopulation of Mesenchymal Stem Cells with Unique Immunomodulatory Properties | PLOS ONE
CD106 Identifies a Subpopulation of Mesenchymal Stem Cells with Unique Immunomodulatory Properties | PLOS ONE
CD106 (VCAM-1) Antibody, anti-human, REAfinity™ | Recombinant antibodies | MACS Antibodies | Products | Miltenyi Biotec | Great Britain
![CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-κB in the bone marrow failure of acquired aplastic anemia | Stem Cell Research & Therapy | Full Text CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-κB in the bone marrow failure of acquired aplastic anemia | Stem Cell Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13287-017-0620-4/MediaObjects/13287_2017_620_Fig2_HTML.gif)
CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-κB in the bone marrow failure of acquired aplastic anemia | Stem Cell Research & Therapy | Full Text
![Single CD271 marker isolates mesenchymal stem cells from human dental pulp | International Journal of Oral Science Single CD271 marker isolates mesenchymal stem cells from human dental pulp | International Journal of Oral Science](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fijos.2015.29/MediaObjects/41368_2015_Article_BFijos201529_Fig1_HTML.jpg)
Single CD271 marker isolates mesenchymal stem cells from human dental pulp | International Journal of Oral Science
![CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-κB in the bone marrow failure of acquired aplastic anemia | Stem Cell Research & Therapy | Full Text CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-κB in the bone marrow failure of acquired aplastic anemia | Stem Cell Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13287-017-0620-4/MediaObjects/13287_2017_620_Fig1_HTML.gif)
CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-κB in the bone marrow failure of acquired aplastic anemia | Stem Cell Research & Therapy | Full Text
![Human epithelial ovarian cancer cells expressing CD105, CD44 and CD106 surface markers exhibit increased invasive capacity and drug resistance Human epithelial ovarian cancer cells expressing CD105, CD44 and CD106 surface markers exhibit increased invasive capacity and drug resistance](https://www.spandidos-publications.com/article_images/ol/17/6/ol-17-06-5351-g00.jpg)
Human epithelial ovarian cancer cells expressing CD105, CD44 and CD106 surface markers exhibit increased invasive capacity and drug resistance
CD106 Identifies a Subpopulation of Mesenchymal Stem Cells with Unique Immunomodulatory Properties | PLOS ONE
![CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-κB in the bone marrow failure of acquired aplastic anemia | Stem Cell Research & Therapy | Full Text CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-κB in the bone marrow failure of acquired aplastic anemia | Stem Cell Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13287-017-0620-4/MediaObjects/13287_2017_620_Fig3_HTML.gif)
CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-κB in the bone marrow failure of acquired aplastic anemia | Stem Cell Research & Therapy | Full Text
![Characterization of the osteogenic potential of mesenchymal stem cells from human periodontal ligament based on cell surface markers | International Journal of Oral Science Characterization of the osteogenic potential of mesenchymal stem cells from human periodontal ligament based on cell surface markers | International Journal of Oral Science](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fijos.2015.42/MediaObjects/41368_2015_Article_BFijos201542_Fig1_HTML.jpg)
Characterization of the osteogenic potential of mesenchymal stem cells from human periodontal ligament based on cell surface markers | International Journal of Oral Science
![Malfunctioning CD106-positive, short-term hematopoietic stem cells trigger diabetic neuropathy in mice by cell fusion | Communications Biology Malfunctioning CD106-positive, short-term hematopoietic stem cells trigger diabetic neuropathy in mice by cell fusion | Communications Biology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs42003-021-02082-5/MediaObjects/42003_2021_2082_Fig6_HTML.png)